Catalyst Wire Dossier Catalyst Wire Dossier

Fludarabine-based conditioning regimen

fludarabine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fludarabine-based conditioning regimen, covering 2016-10-04 to 2016-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) [Phase 1, Phase 2]

See pricing